Carotid artery atherosclerosis: Effect of intensive lipid therapy on the vasa vasorum - Evaluation by using dynamic contrast-enhanced MR imaging

Radiology

Volumn 260, Issue 1, 2011, Pages 224-231

  Dong, Li ^a,b   Kerwin, Williams S ^a,c   Chen, Huijun ^a   Chu, Baocheng ^a   Underhill, Hunter R ^a   Neradilek, Moni Blazej ^d   Hatsukami, Thomas S ^a   Yuan, Chun ^a   Zhao, Xue Qiao ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c VP Diagnostics Inc   (United States)

^d Mountain Whisper Light Statistical Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; C REACTIVE PROTEIN; COLESEVELAM; CONTRAST MEDIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID;

ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG TARGETING; ECHOCARDIOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SHORT COURSE THERAPY; THERAPY EFFECT; TREATMENT DURATION; VASA VASORUM;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEPTANOIC ACIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PYRROLES; TREATMENT OUTCOME; VASA VASORUM;

EID: 79959569664     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101264     Document Type: Article

References (47)

1. Kwon HM, Sangiorgi G, Ritman EL, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998;101(8):1551-1556. (Pubitemid 28198482)
2. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310(3):175-177.
3. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25(10):2054-2061. (Pubitemid 41416300)
4. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation 2006;113(18):2245-2252.
5. Magnoni M, Coli S, Marrocco-Trischitta MM, et al. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr 2009;10(2):260-264.
6. Herrmann J, Lerman LO, Rodriguez-Porcel M, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 2001;51(4):762-766. (Pubitemid 32800717)
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105(9):1135-1143. (Pubitemid 34212626)
8. Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res 2007;75(4):640-648. (Pubitemid 47238746)
9. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349(24):2316-2325. (Pubitemid 37509739)
10. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003;107(6):851-856. (Pubitemid 36241043)
11. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006;241(2):459-468. (Pubitemid 44632892)
12. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 2008;59(3):507-514. (Pubitemid 351348221)
13. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10(3):223-232.
14. Williams JK, Sukhova GK, Herrington DM, Libby P. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 1998;31(3):684-691. (Pubitemid 28144138)
15. Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002;105(4):415-418. (Pubitemid 34141695)
16. Zhao XQ, Phan BA, Chu B, et al. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition study. Am Heart J 2007;154(2):239-246. (Pubitemid 47069140)
17. Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006;19(6):636-654. (Pubitemid 44515609)
18. Kerwin W, Xu D, Liu F, et al. Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging 2007;18(5):371-378. (Pubitemid 350145117)
19. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005;25(1):234-239. (Pubitemid 40054282)
20. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112(22):3437-3444.
21. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94(5):932-938. (Pubitemid 26292843)
22. Chu B, Kampschulte A, Ferguson MS, et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke 2004;35(5):1079-1084. (Pubitemid 38543521)
23. Kerwin WS, Cai J, Yuan C. Noise and motion correction in dynamic contrast-enhanced MRI for analysis of atherosclerotic lesions. Magn Reson Med 2002;47(6):1211-1217. (Pubitemid 34587413)
24. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3(1):1-7. (Pubitemid 13129630)
25. Davison AC, Hinkley DV. Bootstrap methods and their application. Cambridge, England: Cambridge University Press, 1997.
26. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359(21):2195-2207.
27. Hanefeld M, Marx N, Pfützner A, et al. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT study. J Am Coll Cardiol 2007;49(3):290-297. (Pubitemid 46110954)
28. Kinlay S, Schwartz GG, Olsson AG, et al. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol 2008;28(1):142-147.
29. Tang TY, Howarth SP, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study: evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009;53(22):2039-2050.
30. Kamanna VS, Kashyap ML. Mechanism of action of niacin. Am J Cardiol 2008;101(8A):20B-26B.
31. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100(8):4736-4741. (Pubitemid 36457799)
32. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 2007;10(3):149-166.
33. Granada JF, Feinstein SB. Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med 2008;5(suppl 2):S18-S25.
34. Staub D, Schinkel AF, Coll B, et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010;3(7):761-771.
35. Coli S, Magnoni M, Sangiorgi G, et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008;52(3):223-230. (Pubitemid 351915779)
36. Schinkel AF, Krueger CG, Tellez A, et al. Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis. Eur J Echocardiogr 2010;11(8):659-664.
37. Moguillansky D, Leng X, Carson A, et al. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J 2011;32(5):646-653.
38. Takaya N, Cai J, Ferguson MS, et al. Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging 2006;24(1):203-210.
39. Saam T, Hatsukami TS, Yarnykh VL, et al. Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging 2007;26(2):344-352. (Pubitemid 47257733)
40. Underhill H, Yuan C, Zhao X, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008;155(3):e1-e8. [Published correction appears in Am Heart J 2008;155(6):1127.]
41. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106(23):2884-2887. (Pubitemid 35424736)
42. Nasu K, Tsuchikane E, Katoh O, et al. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovasc Interv 2009;2(7):689-696.
43. Zhao XQ, Dong L, Hatsukami TS, et al. Magnetic resonance imaging of the plaque lipid depletion during lipid therapy: a prospective assessment of efficacy and time-course - a late breaking clinical trial report. Presented at the 58th annual meeting of the American College of Cardiology, Orlando, Fla, March 28-31, 2009.
44. Jeziorska M, Woolley DE. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol 1999;188(2):189-196. (Pubitemid 29253939)
45. Ritman EL, Lerman A. The dynamic vasa vasorum. Cardiovasc Res 2007;75(4):649-658. (Pubitemid 47238745)
46. Wasserman BA, Sharrett AR, Lai S, et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke 2008;39(2):329-335. (Pubitemid 351619451)
47. Wagenknecht L, Wasserman B, Chambless L, et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities study. Circ Cardiovasc Imaging 2009;2(4):314-322.